|
|
||||||||
Articles |
1 Laboratory of Neurochemistry, Uriarte 2383, 1425 Buenos Aires, Argentina.
aAuthor for correspondence. Fax 5411-4774-5920; e-mail nachamoles{at}fibertel.com.ar.
Background: Clinical differentiation among mucopolysaccharidosis, oligosaccharidosis, and mucolipidosis II and III is difficult. We describe methods for the assay of 8 lysosomal enzymes in dried blood spots on filter paper that allow screening for 12 lysosomal storage diseases that present with a Hurler-like phenotype.
Methods: To test tubes containing 3-mm blood spots, we added elution liquid and fluorescent or radioactive substrate solution. After incubation at 37 °C, the reaction was terminated by the addition of a stop buffer. The amount of hydrolyzed product was compared with a calibrator to allow the quantification of enzyme activity. Sample stability was studied during storage for 21 days and during shipment of samples. We measured enzyme activities in 85 healthy controls (35 newborn, 50 adult), 57 patients suffering from 11 lysosomal storage diseases, and 46 obligate carriers.
Results: Intra- and interassay CVs were <9% and <15%, respectively. Mean activity losses during transportation or storage for up to 21 days at 4 °C were
27%. Enzyme activities in all patients were outside the ranges of values seen for carriers and controls.
Conclusions: The described methodology distinguishes between patients and controls with samples that are sufficiently stable to be mailed to the testing laboratory.
The following articles in journals at HighWire Press have cited this article:
![]() |
J. Muenzer, J. E. Wraith, L. A. Clarke, and and the International Consensus Panel on the Manag Mucopolysaccharidosis I: Management and Treatment Guidelines Pediatrics, January 1, 2009; 123(1): 19 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Parkinson-Lawrence, M. Fuller, J. J. Hopwood, P. J. Meikle, and D. A. Brooks Immunochemistry of Lysosomal Storage Disorders Clin. Chem., September 1, 2006; 52(9): 1660 - 1668. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Dean, M. R. Bockmann, J. J. Hopwood, D. A. Brooks, and P. J. Meikle Detection of Mucopolysaccharidosis Type II by Measurement of Iduronate-2-Sulfatase in Dried Blood Spots and Plasma Samples Clin. Chem., April 1, 2006; 52(4): 643 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang, B. Eadala, M. Sadilek, N. A. Chamoles, F. Turecek, C. R. Scott, and M. H. Gelb Tandem Mass Spectrometric Analysis of Dried Blood Spots for Screening of Mucopolysaccharidosis I in Newborns Clin. Chem., May 1, 2005; 51(5): 898 - 900. [Full Text] [PDF] |
||||
![]() |
Y. Li, K. Brockmann, F. Turecek, C. R. Scott, and M. H. Gelb Tandem Mass Spectrometry for the Direct Assay of Enzymes in Dried Blood Spots: Application to Newborn Screening for Krabbe Disease Clin. Chem., March 1, 2004; 50(3): 638 - 640. [Full Text] [PDF] |
||||
![]() |
D. A. Wenger, S. Coppola, and S.-L. Liu Insights Into the Diagnosis and Treatment of Lysosomal Storage Diseases Arch Neurol, March 1, 2003; 60(3): 322 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lukacs, P. Santavuori, A. Keil, R. Steinfeld, and A. Kohlschutter Rapid and Simple Assay for the Determination of Tripeptidyl Peptidase and Palmitoyl Protein Thioesterase Activities in Dried Blood Spots Clin. Chem., March 1, 2003; 49(3): 509 - 511. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |